Pulike Biological Engineering, Inc. reported earnings results for the nine months ended September 30, 2022. For the nine months, the company reported sales was CNY 825.71 million compared to CNY 821.02 million a year ago. Revenue was CNY 825.71 million compared to CNY 821.02 million a year ago.

Net income was CNY 132.85 million compared to CNY 230.63 million a year ago. Basic earnings per share from continuing operations was CNY 0.42 compared to CNY 0.73 a year ago. Diluted earnings per share from continuing operations was CNY 0.42 compared to CNY 0.73 a year ago.